TRT and energy claims: what the evidence actually supports

What did @kmartfit actually say?

The claim is straightforward: testosterone replacement therapy raises energy levels, and that energy then converts into drive and motivation. Without it, you can't get off the couch. With it, your life changes. The video ends with a direct pitch: reach out to him and he'll get you started on TRT online.

That's worth separating into two parts. The first is a biological claim about what TRT does. The second is a referral pitch that raises its own questions about who's actually evaluating these patients.

Does the science back this up?

Partially, yes, but the video makes it sound cleaner than the evidence actually is. Fatigue and low energy are real, documented symptoms of hypogonadism, and TRT does improve them in men who are genuinely deficient. But the effect size matters, and it's not universal.

The 2016 Testosterone Trials (Snyder et al., NEJM) found that testosterone treatment in men 65 and older with low testosterone improved self-reported energy and vitality compared to placebo. That's a real finding. But the same trials found the effects were modest and variable. Not every man with low testosterone responded the same way. A 2019 meta-analysis by Corona et al. in the Journal of Sexual Medicine similarly found improvements in fatigue and mood in hypogonadal men on TRT, but noted that men with testosterone in the low-normal range saw smaller benefits. The energy boost @kmartfit describes is real for some men. It is not a guaranteed outcome for all of them.

What did they get wrong (or right)?

They got the core biology roughly right. Low testosterone is associated with fatigue, and TRT addresses that in clinically deficient men. Credit where it's due.

What's missing, and this matters, is any acknowledgment that fatigue has many causes. Sleep apnea, depression, thyroid dysfunction, and poor sleep hygiene all produce identical symptoms. Starting TRT without ruling those out first is a shortcut that can delay a real diagnosis. The 2018 American Urological Association guidelines explicitly recommend a full workup before initiating TRT, including two morning serum testosterone measurements and symptom evaluation.

The claim that TRT is "changing men's lives around the world" is marketing language, not a clinical statement. And the pitch at the end, where @kmartfit offers to "get you the resources to begin your journey on TRT online," is vague enough to be concerning. Who is diagnosing these patients? What labs are being ordered? That's not answered here.

What should you actually know?

If you're genuinely fatigued and suspect low testosterone, the right first step is blood work, not a TikTok DM. Testosterone levels fluctuate across the day, which is why guidelines require two separate morning fasting measurements before a diagnosis of hypogonadism is made.

Normal testosterone ranges are wide, roughly 300 to 1000 ng/dL depending on the lab, and symptoms don't always correlate neatly with numbers. Some men feel fine at 320. Others feel terrible at 420. A good clinician looks at both.

TRT also carries real considerations that go unmentioned here. It suppresses the hypothalamic-pituitary-gonadal axis, which reduces natural testosterone production and can affect fertility. A study by Crosnoe et al. in Fertility and Sterility (2013) documented significant impacts on sperm production in men on exogenous testosterone. That's not a reason to avoid TRT if you need it, but it's absolutely a conversation to have before starting.

Is there anything else worth flagging?

The referral model in this video deserves scrutiny. Telehealth TRT has expanded access for men who genuinely need it, and that's a real benefit. But creator-led patient funnels, where someone with no disclosed clinical credentials offers to connect followers with online TRT providers, sit in a regulatory gray zone. The FDA and FTC have both increased attention on influencer health claims and undisclosed referral arrangements. Viewers should ask whether @kmartfit has a financial relationship with the platform he's referring to, because that disclosure is legally required and notably absent here.